Armata Pharmaceuticals
ARMP · NYSE American
$3.20+$0.13 (+4.23%)TodayMarket closed ·
Prev close $3.07
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 64.0% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.4539 | -$0.27 | +40.5% |
| Q1 FY26 | -$0.3876 | -$3.16 | −715.3% |
| Q4 FY25 | -$0.2856 | -$3.27 | −1045.0% |
| Q3 FY25 | -$0.4284 | -$0.74 | −72.7% |
| Q2 FY25 | -$0.3978 | -$0.45 | −13.1% |
| Q1 FY25 | -$0.3876 | -$0.20 | +48.4% |
| Q4 FY24 | -$0.357 | $0.07 | +119.6% |
| Q3 FY24 | -$0.2856 | -$0.15 | +47.5% |
Earnings calls
- AmpliPhi Biosciences Corp. (APHB) CEO Paul Grint on C3J Therapeutics Merger Conference Call
- Earnings call Q1 2018
- Earnings call Q3 2017
- Earnings call Q2 2017
- Earnings call Q1 2017
- Earnings call Q2 2016
- Earnings call Q1 2016
- Earnings call Q4 2015
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.